IL165562A0 - Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers - Google Patents

Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Info

Publication number
IL165562A0
IL165562A0 IL16556204A IL16556204A IL165562A0 IL 165562 A0 IL165562 A0 IL 165562A0 IL 16556204 A IL16556204 A IL 16556204A IL 16556204 A IL16556204 A IL 16556204A IL 165562 A0 IL165562 A0 IL 165562A0
Authority
IL
Israel
Prior art keywords
prodrugs
treatment
proton pump
imidazole derivatives
pump inhibitors
Prior art date
Application number
IL16556204A
Other languages
English (en)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of IL165562A0 publication Critical patent/IL165562A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16556204A 2002-06-14 2004-12-05 Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers IL165562A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002175086 2002-06-14
JP2003041085 2003-02-19
PCT/JP2003/007546 WO2003105845A1 (en) 2002-06-14 2003-06-13 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Publications (1)

Publication Number Publication Date
IL165562A0 true IL165562A0 (en) 2006-01-15

Family

ID=29738411

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16556204A IL165562A0 (en) 2002-06-14 2004-12-05 Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Country Status (19)

Country Link
US (2) US20060293371A1 (pl)
EP (2) EP1514870A4 (pl)
JP (1) JPWO2003106429A1 (pl)
KR (1) KR20050009751A (pl)
CN (1) CN1678315A (pl)
AR (1) AR040221A1 (pl)
AT (1) ATE437642T1 (pl)
AU (2) AU2003242390A1 (pl)
BR (1) BR0311801A (pl)
CA (2) CA2489361A1 (pl)
DE (1) DE60328603D1 (pl)
IL (1) IL165562A0 (pl)
MX (1) MXPA04012396A (pl)
NO (1) NO20050141L (pl)
OA (1) OA12867A (pl)
PE (1) PE20040563A1 (pl)
PL (1) PL373085A1 (pl)
TW (1) TW200307544A (pl)
WO (2) WO2003105845A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105786A1 (en) 2004-04-28 2005-11-10 Hetero Drugs Limited A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
WO2006090845A1 (ja) 2005-02-25 2006-08-31 Takeda Pharmaceutical Company Limited 顆粒の製造方法
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
EP2252274A4 (en) 2008-02-20 2011-05-11 Univ Missouri COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME
US8722720B2 (en) 2009-10-28 2014-05-13 Newlink Genetics Corporation Imidazole derivatives as IDO inhibitors
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
WO2016172436A1 (en) * 2015-04-23 2016-10-27 Temple University-Of The Commonwealth System Of Higher Education Polycationic amphiphiles and polymers thereof as antimicrobial agents and methods using same
IL283809B2 (en) 2016-06-21 2024-01-01 Univ Columbia Compounds for use in a method for treating neuropathy, retinopathy, nephropathy or cardiomyopathy
US11111216B2 (en) 2016-10-26 2021-09-07 Temple University-Of The Commonwealth System Of Higher Education Polycationic amphiphiles as antimicrobial agents and methods using same
AU2018307964B2 (en) 2017-07-28 2023-11-16 Applied Therapeutics Inc. Compositions and methods for treating galactosemia
JP2022531466A (ja) 2019-05-07 2022-07-06 ユニバーシティ オブ マイアミ 遺伝性ニューロパチーおよび関連障害の処置および検出
JP7404561B2 (ja) * 2020-06-17 2023-12-25 イルドン ファーマシューティカル カンパニー リミテッド 新規な酸分泌抑制剤及びその用途
IT202200001022A1 (it) * 2022-01-21 2023-07-21 Exo Lab Italia Composti farmaceutici ibridi ottenuti mediante coniugazione di un inibitore delle pompe protoniche e un inibitore delle anidrasi carboniche

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
KR890000387B1 (ko) 1984-09-24 1989-03-16 디 엎존 캄파니 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
IL76839A (en) 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4965269A (en) 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
US6542966B1 (en) * 1998-07-16 2003-04-01 Intel Corporation Method and apparatus for managing temporal and non-temporal data in a single cache structure
DE19832060C2 (de) * 1998-07-16 2000-07-06 Siemens Ag Doppelbare Prozessoreinrichtung
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
HUP0202431A3 (en) * 1999-04-09 2003-03-28 Basf Ag Prodrugs of thrombin inhibitors
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
WO2002004452A2 (en) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
WO2002030920A1 (fr) 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation
AU2002303929B9 (en) * 2001-05-31 2007-01-25 E. R. Squibb & Sons, L.L.C. Cytotoxins, prodrugs, linkers and stabilizers useful therefor
WO2003027098A1 (fr) 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci

Also Published As

Publication number Publication date
KR20050009751A (ko) 2005-01-25
EP1513527B1 (en) 2009-07-29
EP1513527A1 (en) 2005-03-16
EP1514870A1 (en) 2005-03-16
US20050222210A1 (en) 2005-10-06
JPWO2003106429A1 (ja) 2005-10-13
PL373085A1 (pl) 2005-08-08
BR0311801A (pt) 2005-04-12
NO20050141L (no) 2005-01-27
OA12867A (en) 2006-09-15
AU2003242388A1 (en) 2003-12-31
MXPA04012396A (es) 2005-06-17
TW200307544A (en) 2003-12-16
US20060293371A1 (en) 2006-12-28
CN1678315A (zh) 2005-10-05
WO2003106429A1 (ja) 2003-12-24
PE20040563A1 (es) 2004-10-21
WO2003105845A1 (en) 2003-12-24
ATE437642T1 (de) 2009-08-15
CA2489470A1 (en) 2003-12-24
US7410981B2 (en) 2008-08-12
CA2489361A1 (en) 2003-12-24
DE60328603D1 (de) 2009-09-10
AU2003242390A1 (en) 2003-12-31
NO20050141D0 (no) 2005-01-11
EP1514870A4 (en) 2006-08-23
AR040221A1 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
NO20050141D0 (no) Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus
AU2003213768A1 (en) Use of benzimidazole analogs in the treatment of cell proliferation
WO2010038086A8 (en) P38 map kinase inhibitors
UA104731C2 (ru) Ингибиторы р38 мар-киназ
EP1803709A4 (en) PROTON PUMP INHIBITORS
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
AU2003258441A1 (en) System for performing proton therapy
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AU2003241464A1 (en) Compositions and methods using proton pump inhibitors
GEP20084499B (en) USE OF INTERFERON-ß FOR TREATMENT OF RENAL FAILURE
EP1534278A4 (en) NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
WO2007120333A3 (en) Tetracyclic kinase inhibitors
AU2002366796A8 (en) Methods using proton pump inhibitors
HUE052154T2 (hu) Rövid felezési idejû C1 inhibitor tranziens kezeléshez
HK1072379A1 (en) Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
IL150062A0 (en) Proton pump inhibitors
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
GB0403165D0 (en) Novel uses for proton pump inhibitors
WO2004098599A3 (en) Proton pump inhibitors for the treatment of lower abdominal disorders
TW200509921A (en) Alkaline salts
GEP20094699B (en) THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING ß-INTERFERON
WO2003094967A3 (en) New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
MY140194A (en) Novel fusidic acid derivatives
AU2003205452A1 (en) Bmp inhibitors for the treatment of spondyloarthropathies
WO2003043614A3 (en) Reversible proton pump inhibitors for the treatment of airway disorders